Description

Terazidine® – Trimetazidine Hydrochloride 35 mg Modified-Release Tablet is a prescription cardiovascular medicine classified as an anti-anginal agent. It contains Trimetazidine Hydrochloride, formulated as a modified-release tablet.

  • Brand: Terazidine®
  • Active ingredient: Trimetazidine Hydrochloride 35 mg
  • Dosage form: Modified-release tablet
  • Pack size: 100 tablets
  • Therapeutic class: Anti-anginal agent
  • Classification: Prescription medicine (Rx)
  • Manufacturer: Magbro Healthcare Pvt. Ltd., India
  • Imported & distributed by: Teramedix Pharma Trading Inc., Makati City, Metro Manila, Philippines
  • Route: Oral

General use: Trimetazidine is used as an add-on treatment for stable angina in certain patients when other anti-anginal treatments are insufficient or not tolerated.

Important: This is a prescription medicine and should be used only under the direction of a licensed healthcare professional.